Keywords
organophosphate
cholinesterase inhibitors
heart fatilure
morphology
morphometry
How to Cite
Abstract
Organophosphate can be responsible for causing acute intoxications, and in inducing delayed effects. Effects on the cardio-vascular system after long-term exposition to organophosphate have not been described, so far. The objective of the present study was to study whether these effects on heart could be caused by these compounds contact. Adult male Wistar albino rats, divided into groups, received weekly an enteral sub-lethal dose of organophosphate methamidophos for 12 consecutive weeks. Then, their hearts were examined by means of histological and morphometric methods. Hipertrophy of cardiac muscle cells in treated animals was observed, and this finding was confirmed by means of morphometric methods, that is, the measurement of smallest diameter of cardiac muscular cells. The mean value of the smallest diameter of cardiac myocytes from controls was 64.93 + 5.82μm, and from two treated animals groups was 82.24+12.39μm and 88.88 + 10.19 μm, respectively. Although the functional consequences of cardiac hypertrophy were not the object of the present study, the 3 month-treated animals did not show any sign of heart failure. However, it could not be disregarded that long term exposition to organophosphate might cause any functional cardiac disorder, including heart failure. These heart histology alterations are relevant, as Brazilian people are frequently undergo to long-term exposure to these compound with deleterious results.References
1. Gordon CJ, Padnos BK. Prolonged elevation in blood pressurein the unrestrained rat exposed to chlorpyrifos. Toxicology.2000; 146(1): 1–13.
2. Cavanagh JB. The toxic effects of tri-ortho-cresyl phosphateon nervous system; an experimental study in hens. J NeurolNeurosurg Psychiatr. 1954; 17:163-72.
3. Sprague GL, Bickford AA. Effect of multipledi isopropylfluorophosphate injections in hens: a behavioral biochemical and histological investigation. J Toxicol EnvironHealth. 1981; 8 (5-6): 973-88.
4. Johnson MK. Organophosphates and delayed neuropathy -Its NTE alive and well? Toxicol Appl Pharmacol. 1990;102(3):385-99.
5. Lotti M. The pathogenesis of organophosphate polyneuropathy.Crit. Rev Toxicol.1992 1; 21(6):465-87.
6. Rosenstock L, Keifer M, Daniell WE, mc Monnell R, Claypoole K. The Pesticide Health Effects Study Group. Chronic central nervous system effects of acute organophosphate pesticide intoxication. Lancet. 1991;(8761)338:223-37.
7. Levin HS, Rodnitzky RL. Behavioral effects of organophosphate in man. Clin Toxicol, 1976; 9(3): 391-403.
8. Kamiya H, Okumura K, Ito M, Saburi Y, Tomida T, HayashiK, Matsui H, Hayakawa T. Calcineurin inhibitor attenuates cardiac hypertrophy due to energy metabolic disorder. Can JCardiol. 2001; 17(12): 1292-8.
9. Socko R, Gralewicz S, Gorny R. Long-term behavioral effects of a repeated exposure to chlorphenvinphos in rats. Int Occup Med Environ Heath. 1999:12: (2): 105-17.
10. Etri MM, Nickell WT, Ennis M, Skau K, Shipley MT. Brainnor epinephrine reductions in soman-intoxicated rats: associationwith convulsions and Ache inhibition, time course, and relationto other monoamines. Exp Neurol. 1992; 118(2): 153-63.
11. Britt, JO, Martin JL, Okerberg CV, Dick EJJr. Histopathologic changes in the brain, heart and skeletal muscle of RhesusMacaques, tem days after exposure to soman norgganophosphorus nerve agent. Comp Med. 2000; 50(2): 133-9.
12. Kassa J, Koupilová M, Herink J, Vachek J. Long- terminfluence of low-level sarin exposure on behavioral and neurophysiological functions in rats. Acta Medica. 2001; 44(1):21-7.
13. Ellman GL, Coutney KD, Andres VJr. Feather-Stone RM. Anew rapid colorimetric determination of acethylcholinesterase activity. Biochem Pharmacol. 1961;7:88-95.
14. Wilheim K. Determination of human plasma cholinesterase activity by adapted Ellman method. Arh Hig Rad Tokskol.1967; 19:199-207.
15. Saadeh AM, Farsakh NA, al-Ali MK. Cardiac manifestations of acute carbamate and organophosphate poisoning. Heart.1997; 77(5): 461-4.
16. Smith EC, Padnos B, Gordon CJ. Peripheral versus centralmuscarinic effects on blood pressure, cardiac contractility, heartrate, and body temperature in the rat monitored byradiotelemetry. Pharmacol Toxicol. 2001;89(1):35- 42.
17. Yen DH, Yen JC, Len WB, Wang LM, Lee CH, Chan SH.Spectral changes in systemic arterial pressure signals during acutemevinphos intoxication in the rat. Shock. 2001; 15(1): 35-41.
18. Kamiya H, Okumura K, Ito M, Saburi Y, Tomida T, HayashiK, Matsui H, Hayakawa T. Calcineurin inhibitor attenuates cardiac hypertrophy due to energy metabolic disorder. Can JCardiol. 2001; 17(12): 1292-8.
19. Sangaralingham SJ, Pak BJ, Tse MY, Angelis E, Adams MA, Smallegange C, Pang SC. Expression of the translational repressor NAT1 in experimental models of cardiachy pertrophy. Mol Cell Biochem. , 2003; 245 (1-2): 183-90.
20. Freed DH, Moon MC, Borowiec AM, Jones SC, Zahradka P, Dixon IM. Cardiotrophin-1: expression inexperimental myocardial infarction and potential role inpost-MI wound healing. Mol Cell Biochem. 2003; 254(1-2): 247-56.
This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright (c) 2006 Instituto Adolfo Lutz Journal